by Proxiva Peptides | Mar 5, 2026 | Research Guides
The 2026 Peptide Clinical Trial Landscape The peptide therapeutics pipeline has never been more robust. As of early 2026, over 150 peptide-based drugs are in active clinical development, spanning metabolic diseases, oncology, infectious diseases, neurology, and...
by Proxiva Peptides | Mar 5, 2026 | Research Guides
The Foundation: Understanding Amino Acids Amino acids are the fundamental building blocks of all peptides and proteins. These small organic molecules share a common core structure: a central alpha carbon bonded to an amino group (-NH2), a carboxyl group (-COOH), a...
by Proxiva Peptides | Mar 5, 2026 | Research Guides
Understanding Peptide Pharmacokinetics The half-life of a peptide — the time required for its concentration in the body to decrease by half — is one of the most critical parameters in peptide research. It determines dosing frequency, peak and trough concentrations,...
by Proxiva Peptides | Mar 5, 2026 | Research Guides
What Is Peptide Therapy? Peptide therapy refers to the therapeutic use of specific peptides — short chains of amino acids typically ranging from 2 to 50 amino acids in length — to trigger targeted biological responses in the body. Unlike traditional small-molecule...
by Proxiva Peptides | Mar 4, 2026 | Research Guides
Peptides are among the most fundamental signaling molecules in human biology, yet their mechanisms of action remain poorly understood by many entering the research field. These short chains of amino acids orchestrate an astonishing array of biological processes — from...
